Skip to main content
SpringerLink
Log in
Book cover

Neuroimmunology of the Skin pp 187–196Cite as

Neuroimmunologic Cascades in the Pathogenesis of Psoriasis and Psoriatic Arthritis

  • Chapter

  • 1186 Accesses

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   89.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Abbreviations

CGRP :

Calcitonin gene-related protein

NGF :

Nerve growth factor

NGF-R :

Nerve growth factor receptor

p75 NTR :

p75 neurotrophin receptor

RANTES :

regulated upon activation, normal T cell expressed and secreted

SCID :

Severe combined immunodeficient

SP :

Substance P

TrkA :

Receptor tyrosine kinase A

VIP :

Vasoactive intestinal peptide

References

  1. Al’Abadie MSK, Senior HJ, Bleehen SS, et al (1992) Neurogenic changes in psoriasis. An immunohistochemical study. J Invest Dermatol 98:535

    Google Scholar 

  2. Aloe L, Levi-Mantalcini R (1977) Mast cells increase in tissues of neonatal rats injected with the nerve growth factor. Brain Res 133:358–366

    Article  PubMed  CAS  Google Scholar 

  3. Aloe L, Alleva E, De Simone R (1990) Changes of NGF level in mouse hypothalamus following intermale aggressive behavior: biological and immunohistochemical evidence. Behav Brain Res 39:53–61

    Article  PubMed  CAS  Google Scholar 

  4. Aloe L, Probert L, Kollias G, et al (1993) The synovium of transgenic arthritic mice expressing human tumor necrosis factor contains a high level of nerve growthfactor. Growth Factors 9:149–155

    Article  PubMed  CAS  Google Scholar 

  5. Babu RJ, Kikwai L, Jaiani LT, et al (2004) Percutaneous absorption and anti-inflammatory effect of a substance P receptor antagonist: spantide II. Pharm Res 21:108–113

    Article  PubMed  CAS  Google Scholar 

  6. Bischoff SC, Dahinden CA (1992) Effect of nerve growth factor on the release of inflammatory mediators by mature human basophils. Blood 79:2662–2669

    PubMed  CAS  Google Scholar 

  7. Borson DB, Gruenert DC (1991) Glucocorticoids induce neutral endopeptidase in transformed human tracheal epithelial cells. Am J Physiol 260:L83–L89

    PubMed  CAS  Google Scholar 

  8. Bos JD, Hulsebosch HJ, Krieg SR, et al (1983) Immunocompetent cells in psoriasis: in situ immunophenotyping with monoclonal antibodies. Arch Dermatol Res 275:181–189

    Article  PubMed  CAS  Google Scholar 

  9. Bernstein JE, Parish LC, Rapaport M, et al (1986) Effects of topically applied capsaicin on moderate and severe psoriasis vulgaris. J Am Acad Dermatol 15:504–507

    Article  PubMed  CAS  Google Scholar 

  10. Calvo CF, Chavanel G, Senik A (1992) Substance P enhances interleukin-2 expression in activated human T cells. J Immunol 148:3498–3504

    PubMed  CAS  Google Scholar 

  11. Camisa C, O’Dorisio TM, Maceyko RF, et al (1990) Treatment of psoriasis with chronic subcutaneous administration of somatostatin analog 201–295 (sandostatin). An open lable pilot study. Clev Clin J Med 57:71–76

    CAS  Google Scholar 

  12. Chan J, Smoller BR, Raychaudhuri SP, et al (1997) Intraepidermal nerve fiber expression of calcitonin generelated peptide, vasoactive intestinal peptide and substance P in psoriasis. Arch Dermatol Res 289:611–616

    Article  PubMed  CAS  Google Scholar 

  13. Chang JC, Smith LR, Froning KJ, et al (1997) Persistance of T-cell clones in psoriatic lesions. Arch Dermatol 133:703–708

    Article  PubMed  CAS  Google Scholar 

  14. Erdos EG, Skidgel RA (1989) Neutral endopeptidase and related regulators of peptide hormones. FASEB J 3:145–151

    PubMed  CAS  Google Scholar 

  15. Fantini F, Magnoni C, Brauci-Laudeis L, Pincelli C (1995) Nerve growth factor is increased in psoriatic skin. J Invest Dermatol 105:854–855

    Article  PubMed  CAS  Google Scholar 

  16. Farber EM, Peterson JB (1961) Variations in the natural history of psoriasis. Calif Med 95:6–11

    PubMed  CAS  Google Scholar 

  17. Farber EM, Raychaudhuri SP (1997) Concept of total care: a third dimension in the treatment of psoriasis. Cutis 59:35–39

    PubMed  CAS  Google Scholar 

  18. Farber EM, Nickoloff BJ, Recht B, et al (1986) Stress, symmetry, and psoriasis: possible role of neuropeptides. J Am Acad Dermatol 14:305–311

    Article  PubMed  CAS  Google Scholar 

  19. Farber EM, Cohen EN, Trozak DJ, et al (1991) Peptide T improves psoriasis when infused into lesions in nanogram amounts. J Am Acad Dermatol. 25:658–664

    Article  PubMed  CAS  Google Scholar 

  20. Farber EM, Rein G, Lanigan SW (1991) Stress and psoriasis — psychoneuroimmunologic mechanisms. Int J Dermatol 30:8–12

    Article  PubMed  CAS  Google Scholar 

  21. Fitzgerald M (1983) Capsaicin and sensory neurons: a review. Pain 15:109–130

    Article  PubMed  CAS  Google Scholar 

  22. Gottlieb AB, Lebwohl M, Shirin S, et al (2000) Anti-CD4 monoclonal antibody treatment of moderate to severe psoriasis vulgaris: results of a pilot, multicenter, multiple-dose, placebo-controlled study. J Am Acad Dermatol 43:595–604

    Article  PubMed  CAS  Google Scholar 

  23. Gozes Y, Brenneman DE, Fridkin M, et al (1991) A VIP antagonist distinguishes spinal cord receptors on spinal cord cells and lymphocytes. Brain Res 540:319–321

    Article  PubMed  CAS  Google Scholar 

  24. Haegerstrand A, Jonzon B, Dalsgaard CJ, et al (1989) Vasoactive intestinal polypeptide stimulates cell proliferation and adenylate cyclase activity of cultured human keratinocytes. Proc Natl Acad Sci USA 86:5993–5996

    Article  PubMed  CAS  Google Scholar 

  25. Hagerstrand A, Dalsgaard CJ, Jonzon B, et al (1990) Calcitonin gene-related peptide stimulates proliferation of human endothelial cells. Proc Natl Acad Sci USA 87:3299–3303

    Article  Google Scholar 

  26. Halliday DA, Zettler C, Rush RA, et al (1998) Elevated nerve growth factor levels in the synovial fluid of patients with inflammatory joint disease. Neurochem Res 23:919–922

    Article  PubMed  CAS  Google Scholar 

  27. Hughes HH, England R, Goldsmith DA (1981) Biofeedback and psychotherapeutic treatment of psoriasis: a brief report. Psycho Rep 48:99–102

    CAS  Google Scholar 

  28. Johansson O, Hilliges M, Talme T, et al (1994) Somatostatin immunoreactive cells in lesional psoriatic human skin during Peptide T treatment. Acta Derm Venereol (Stockh) 74:106–109

    CAS  Google Scholar 

  29. Kane D, Lockhart JC, Balint PV, et al (2005). Protective effect of sensory denervation in inflammatory arthritis (evidence of regulatory neuroimmune pathways in the arthritic joint). Ann Rheum Dis 64:325–327

    Article  PubMed  CAS  Google Scholar 

  30. Krumins SA, Broomfield C (1992) Evidence of NK 1 and NK 2 tachykinin receptors and their involvement in histamine release in a murine mast cell line. Neuropeptides 21:65–72

    Article  PubMed  CAS  Google Scholar 

  31. Lambiase A, Bracci-Laudiero L, Bonini S, et al (1997) Human CD4 + T cell clones produce and release nerve growth factor and express high-affinity nerve growth factor receptors. J Allergy Clin Immunol 100:408–414

    Article  PubMed  CAS  Google Scholar 

  32. Leeman SE, Krause JE, Lembeck F (eds) (1991) Substance P and related peptides: cellular and molecular physiology. 18–21 July 1990, Worcester, Massachusetts, Proceedings; Ann NY Acad Sci 632:1–58, 263–271

    Google Scholar 

  33. Lei YH, Barnes PJ, Rogers DF (1992) Inhibition of neurogenic plasma exudation in guinea-pig airways by CP-96, 345, a new nonpeptide NK1 receptor antagonist. Br J Pharmacol 105:261–262

    PubMed  CAS  Google Scholar 

  34. Lindsay RM, Harmar AJ (1989) Nerve growth factor regulates expression of neuropeptides genes in adult sensory neurons. Nature 337:362–364

    Article  PubMed  CAS  Google Scholar 

  35. Luppi P, Levi-Montalcini R, Bracci-Laudiero L, et al (1993) NGF is released into plasma during human pregnancy: an oxytocin-mediated response? Neuroreport 4:1063–1065

    Article  PubMed  CAS  Google Scholar 

  36. Manni L, Lundeberg T, Fiorito S, et al (2003) Nerve growth factor release by human synovial fibroblasts prior to and following exposure to tumor necrosis factor-alpha, interleukin-1 beta and cholecystokinin-8: the possible role of NGF in the inflammatory response. Clin Exp Rheumatol 21:6176–6124

    Google Scholar 

  37. Marcer D (1986) Biofeedback and Related Therapies in Clinical Practice. Aspen Publishers, Rockville, MD

    Google Scholar 

  38. Marcusson JA, Lazega D, Pert CB, et al (1989) Peptide T and psoriasis. Acta Derm Venereol Suppl (Stockh) 146:117–121

    CAS  Google Scholar 

  39. Matsuda H, Koyama H, Sato H, et al (1998) Role of nerve growth factor in cutaneous wound healing: accelerating effects in normal and healing-impaired diabetic mice. J Exp Med 187:297–306

    Article  PubMed  CAS  Google Scholar 

  40. Nadel JA (1991) Neutral endopeptide modulates neurogenic inflammation. Eur Respir J 4:745–754

    PubMed  CAS  Google Scholar 

  41. Naukkarinen A, Nickoloff BJ, Farber EM (1989) Quantification of cutaneous sensory nerves and their substance P content in psoriasis. J Invest Dermatol 92:126–129

    Article  PubMed  CAS  Google Scholar 

  42. O’Connor TM, O’Connell J, O’Brien DI, et al (2004) The role of substance P in inflammatory diseases. J Cell Physiol 201:167–180

    Article  PubMed  CAS  Google Scholar 

  43. Pearce FL, Thompson HL (1986) Some characteristics of histamine secretion from rat peritoneal mast cells stimulated with nerve growth factor. J Physiol 372:379–393

    PubMed  CAS  Google Scholar 

  44. Pincelli C, Haake AR, Benassi L, et al (1997) Autocrine nerve growth factor protects human keratinocytes from apoptosis through its high affinity receptor (TRK): a role for BCL-2. J Invest Dermatol 109:757–764

    Article  PubMed  CAS  Google Scholar 

  45. Rabier M, Wilkinson DI (1991) Neuropeptides modulate Leukotrine B4 Mitogenicity toward cultured keratinocytes. Clin Res 39:536a

    Google Scholar 

  46. Radhakrishna V, Henry JL (1991) Novel substance P antagonist, CP-96, 345, blocks responses of cat spinal dorsal horn neurons to noxious cutaneous stimulation and substance P. Neurosci Lett 132:39–43

    Article  Google Scholar 

  47. Raychaudhuri SP, Farber EM (1993) Are sensory nerves essential for the development of psoriasis lesions? J Am Acad Dermatol 28:488–489

    Article  PubMed  CAS  Google Scholar 

  48. Raychaudhuri SP, Gross J (2000) A comparative study of pediatrie onset psoriasis with adult onset psoriasis. Pediatr Dermatol 17:174–178

    Article  PubMed  CAS  Google Scholar 

  49. Raychaudhuri SP, Gross J (2000) Psoriasis risk factors: role of lifestyle practices. Cutis 66:348–352

    PubMed  CAS  Google Scholar 

  50. Raychaudhuri SP, Jiang W-Y, Farber EM (1998) Psoriatic keratinocytes express high levels of nerve growth factor. Acta Derm Venereol 78:84–86

    Article  PubMed  CAS  Google Scholar 

  51. Raychaudhuri SP, Farber EM, Raychaudhuri SK (1999) Immunomodulatory effects of peptide T on Th 1/Th 2 cytokines. Int J Immunopharmacol 21:609–615

    Article  PubMed  CAS  Google Scholar 

  52. Raychaudhuri SP, Jiang WY, Farber EM, et al (1999) Upregulation of RANTES in psoriatic keratinocytes: a possible pathogenic mechanism for psoriasis. Acta Derm Venereol 79:9–11

    Article  PubMed  CAS  Google Scholar 

  53. Raychaudhuri SP, Farber EM, Raychaudhuri SK (2000) Role of nerve growth factor in RANTES expression by keratinocytes. Acta Derm Venereol 80:247–250

    Article  PubMed  CAS  Google Scholar 

  54. Raychaudhuri SP, Dutt S, Raychaudhuri SK, et al (2001) Severe combined immunodeficiency mouse-human skin chimeras: a unique animal model for the study of psoriasis and cutaneous inflammation. Br J Dermatol 144:931–939

    Article  PubMed  CAS  Google Scholar 

  55. Raychaudhuri SP, Sanyal M, Weltman H, et al (2004) K252a, a high-affinity nerve growth factor receptor blocker, improves psoriasis: an in vivo study using the severe combined immunodeficient mouse-human skin model. J Invest Dermatol 122:812–819

    Article  PubMed  CAS  Google Scholar 

  56. Raychaudhuri SP, Jiang WY, Raychaudhuri SK (2008) Revisiting the Koebner phenomenon: role of NGF and its receptor system in the pathogenesis of psoriasis. Am J Pathol 172:961–971

    Article  PubMed  CAS  Google Scholar 

  57. Ruff MR (1989) Peptide T. Drugs Future 14:1049–1051

    Google Scholar 

  58. Schall TJ (1991) Biology of the RANTES/SIS cytokine family. Cytokine 3:165–183

    Article  PubMed  CAS  Google Scholar 

  59. Scholzen TE, Steinhoff M, Bonaccorsi P, et al (2001) Neutral endopeptidase terminates substance P-induced inflammation in allergie contact dermatitis. J Immunol 166:1285–1291

    PubMed  CAS  Google Scholar 

  60. Schwartz J, Pearson J, Johnson E (1982) Effect of exposure to anti-NGF on sensory neurons of adult rats and guinea pigs. Brain Res 244:378–381

    Article  PubMed  CAS  Google Scholar 

  61. Smith HC, Barker JN, Morris RW, et al (1993) Neuropeptides induce rapid expression of endothelial cell adhesion molecules and elicit granulocytic infiltration in human skin. J Immunol 151:3274–3282

    PubMed  CAS  Google Scholar 

  62. Snider RM, Constantine JW, Lowe JA, et al (1991) A potent nonpeptide antagonist of the substance P (NK1) receptor. Science 251:435–437

    Article  PubMed  CAS  Google Scholar 

  63. Talme T, Lund-Rosell B, Sundquist KG, et al (1994) Peptide T: a new treatment for psoriasis? Acta Derm Venereol (Stockh) 186:76–78

    CAS  Google Scholar 

  64. Thorpe LW, Werrbach-Perez K, Perez-Polo JR (1987) Effects of nerve growth factor on the expression of IL-2 receptors on cultured human lymphocytes. Ann NY Acad Sci 496:310–311

    Article  PubMed  CAS  Google Scholar 

  65. Valdimarsson H, Baker BS, Jonsdottir I, et al (1986) Psoriasis: a disease of abnormal keratinocyte proliferation induced by T lymphocytes. Immunol Today 7:256–259

    Article  Google Scholar 

  66. Vaupel R, Jarry H, Schlomer HT, et al (1988) Differential response of substance P containing subtypes of adrenomedullary cells to different Stressors. Endocrinology 123: 2140–2145

    Article  PubMed  CAS  Google Scholar 

  67. Wallengren J (1991) Substance P antagonist inhibits immediate and delayed type cutaneous hypersensitivity reactions. Br J Dermatol 124:324–328

    Article  PubMed  CAS  Google Scholar 

  68. Wallengren J, Moller H (1988) Some neuropeptides as modulators of experimental contact allergy. Contact Dermatitis 19:351–354

    Article  PubMed  CAS  Google Scholar 

  69. Wallengren J, Ekman R, Sunder F (1987) Occurrence and distribution of neuropeptides in human skin. An immunocytochemical and immunohistochemical study on normal skin and blister fluid from inflamed skin. Acta Derm Venereol (Stockh) 67:185–192

    CAS  Google Scholar 

  70. Waxman D (1973) Behavior therapy of psoriasis — a hypnoanalytic and counter conditioning technique. Postgrad Med J 49:591–595

    Article  PubMed  CAS  Google Scholar 

  71. Wetterberg L, Alexius B, Saaf J, et al (1987) Peptide T in treatment of AIDS (letter). Lancet 1:159

    Article  PubMed  CAS  Google Scholar 

  72. Wiesenfeld-Hallin Z, Xu Xj, Hakanson R, et al (1990) The specific antagonistic effect of intrathecal spantide II on substance P stimulation-induced facilitation of the nociceptive flexor reflex in rat. Brain Res 526:284–290

    Article  PubMed  CAS  Google Scholar 

  73. Wilkinson DI (1989) Mitogenic effect of substance P and CGRP on Keratinocytes. J Cell Biol 107:509a

    Google Scholar 

  74. Wilkinson DI, Theeuwes MI, Farber EM (1994) Nerve growth factor increases the mitogenicity of certain growth factors for cultured human keratinocytes: A comparison with epidermal growth factor. Exp Dermatol 3:239–245

    Article  PubMed  CAS  Google Scholar 

  75. Wrone-Smith T, Nickoloff BJ (1996) Dermal injection of immunocytes induces psoriasis. J Clin Invest 98:1878–1887

    Article  PubMed  CAS  Google Scholar 

  76. Wyatt S, Shooeter EM, Davies AM (1990) Expression of the NGF receptor gene in sensory neurons and their cutaneous targets prior to and during innervation. Neuron 2:421–427

    Article  Google Scholar 

  77. Xu Xj, Hao JX, Wiesenfeld-Hallin Z, et al (1991) Spantide II, a novel tachykinin antagonist inhibits plasma extravasation induced by antidromic C-fiber stimulation in rat hind paw. Neuroscience 42:731–737

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. 1911, Geneva Place, Davis, CA, 95618, USA

    S. P. Raychaudhuri

  2. Department of Genetics, Stanford University School of Medicine, Palo Alto, CA, 94305, USA

    S. K. Raychaudhuri

Authors
  1. S. P. Raychaudhuri
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S. K. Raychaudhuri
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to S. P. Raychaudhuri .

Editor information

Editors and Affiliations

  1. Weill Cornell Medical College Department of Dermatology, Cornell University, 1300 York Ave., 10021, New York, NY, USA

    Richard D. Granstein MD

  2. Medizinische Einrichtungen Klinik und Poliklinik für, Universitätsklinikum Münster, Von-Esmarch-Str. 56, 48149, Münster, Germany

    Thomas A. Luger MD

Rights and permissions

Reprints and permissions

Copyright information

© 2009 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Raychaudhuri, S.P., Raychaudhuri, S.K. (2009). Neuroimmunologic Cascades in the Pathogenesis of Psoriasis and Psoriatic Arthritis. In: Granstein, R.D., Luger, T.A. (eds) Neuroimmunology of the Skin. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-35989-0_17

Download citation

  • DOI: https://doi.org/10.1007/978-3-540-35989-0_17

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-35986-9

  • Online ISBN: 978-3-540-35989-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation